Research Paper Volume 5, Issue 2 pp 100—110
Rapamycin extends life span of Rb1+/− mice by inhibiting neuroendocrine tumors
Figure 3. Summary of eRapa effects in the Rb1+/− model of neuroendocrine tumorigenesis. Our MRI data are consistent with a delay of tumor development perhaps by inhibition of atypical proliferates and reduction in tumor growth. eRapa may inhibit lung metastasis and slow their growth.